nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C9—brain cancer	0.669	1	CbGaD
Tolterodine—CYP2D6—Lomustine—brain cancer	0.0723	0.303	CbGbCtD
Tolterodine—CYP2D6—Hydroxyurea—brain cancer	0.0548	0.23	CbGbCtD
Tolterodine—CYP3A4—Temozolomide—brain cancer	0.0541	0.227	CbGbCtD
Tolterodine—CYP3A4—Lomustine—brain cancer	0.046	0.193	CbGbCtD
Tolterodine—CYP3A4—Etoposide—brain cancer	0.0111	0.0466	CbGbCtD
Tolterodine—Disorientation—Lomustine—brain cancer	0.00242	0.0346	CcSEcCtD
Tolterodine—Influenza-like symptoms—Temozolomide—brain cancer	0.0016	0.0229	CcSEcCtD
Tolterodine—Disorientation—Procarbazine—brain cancer	0.00153	0.022	CcSEcCtD
Tolterodine—Memory impairment—Temozolomide—brain cancer	0.00146	0.0208	CcSEcCtD
Tolterodine—Visual impairment—Lomustine—brain cancer	0.00144	0.0206	CcSEcCtD
Tolterodine—Infection—Carboplatin—brain cancer	0.00121	0.0173	CcSEcCtD
Tolterodine—Disorientation—Hydroxyurea—brain cancer	0.00119	0.017	CcSEcCtD
Tolterodine—Influenza like illness—Temozolomide—brain cancer	0.00111	0.0159	CcSEcCtD
Tolterodine—Dry eye—Temozolomide—brain cancer	0.00106	0.0151	CcSEcCtD
Tolterodine—Infection—Lomustine—brain cancer	0.00106	0.0151	CcSEcCtD
Tolterodine—Pain—Carboplatin—brain cancer	0.00104	0.0149	CcSEcCtD
Tolterodine—Abnormal vision—Carmustine—brain cancer	0.00103	0.0148	CcSEcCtD
Tolterodine—Abnormal vision—Temozolomide—brain cancer	0.000997	0.0143	CcSEcCtD
Tolterodine—Hallucination—Procarbazine—brain cancer	0.000945	0.0135	CcSEcCtD
Tolterodine—Flushing—Procarbazine—brain cancer	0.000881	0.0126	CcSEcCtD
Tolterodine—Dysuria—Hydroxyurea—brain cancer	0.000858	0.0123	CcSEcCtD
Tolterodine—Weight increased—Hydroxyurea—brain cancer	0.000835	0.012	CcSEcCtD
Tolterodine—Dry skin—Temozolomide—brain cancer	0.000761	0.0109	CcSEcCtD
Tolterodine—Phenprocoumon—CYP2C9—brain cancer	0.000742	0.569	CrCbGaD
Tolterodine—Hallucination—Hydroxyurea—brain cancer	0.000731	0.0105	CcSEcCtD
Tolterodine—Arthralgia—Procarbazine—brain cancer	0.000704	0.0101	CcSEcCtD
Tolterodine—Anxiety—Procarbazine—brain cancer	0.000701	0.01	CcSEcCtD
Tolterodine—Bronchitis—Temozolomide—brain cancer	0.00069	0.00987	CcSEcCtD
Tolterodine—Dry mouth—Procarbazine—brain cancer	0.000688	0.00985	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Etoposide—brain cancer	0.000686	0.00982	CcSEcCtD
Tolterodine—Confusional state—Procarbazine—brain cancer	0.00068	0.00974	CcSEcCtD
Tolterodine—Oedema—Procarbazine—brain cancer	0.000675	0.00966	CcSEcCtD
Tolterodine—Dysuria—Temozolomide—brain cancer	0.000671	0.0096	CcSEcCtD
Tolterodine—Infection—Procarbazine—brain cancer	0.00067	0.00959	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000667	0.00954	CcSEcCtD
Tolterodine—Tachycardia—Procarbazine—brain cancer	0.000658	0.00942	CcSEcCtD
Tolterodine—Weight increased—Temozolomide—brain cancer	0.000653	0.00934	CcSEcCtD
Tolterodine—Urinary tract infection—Carmustine—brain cancer	0.000643	0.00921	CcSEcCtD
Tolterodine—Urinary tract infection—Temozolomide—brain cancer	0.000622	0.0089	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000615	0.0088	CcSEcCtD
Tolterodine—Sinusitis—Temozolomide—brain cancer	0.0006	0.00859	CcSEcCtD
Tolterodine—Somnolence—Procarbazine—brain cancer	0.0006	0.00858	CcSEcCtD
Tolterodine—Hallucination—Carmustine—brain cancer	0.000591	0.00846	CcSEcCtD
Tolterodine—Oedema peripheral—Carmustine—brain cancer	0.000585	0.00838	CcSEcCtD
Tolterodine—Fatigue—Procarbazine—brain cancer	0.000582	0.00833	CcSEcCtD
Tolterodine—Constipation—Procarbazine—brain cancer	0.000577	0.00826	CcSEcCtD
Tolterodine—Pain—Procarbazine—brain cancer	0.000577	0.00826	CcSEcCtD
Tolterodine—Visual impairment—Carmustine—brain cancer	0.000572	0.00819	CcSEcCtD
Tolterodine—Hallucination—Temozolomide—brain cancer	0.000571	0.00818	CcSEcCtD
Tolterodine—Oedema peripheral—Temozolomide—brain cancer	0.000565	0.0081	CcSEcCtD
Tolterodine—Brompheniramine—CYP2C9—brain cancer	0.000563	0.431	CrCbGaD
Tolterodine—Feeling abnormal—Procarbazine—brain cancer	0.000556	0.00796	CcSEcCtD
Tolterodine—Visual impairment—Temozolomide—brain cancer	0.000553	0.00792	CcSEcCtD
Tolterodine—Gastrointestinal pain—Procarbazine—brain cancer	0.000552	0.0079	CcSEcCtD
Tolterodine—Flushing—Carmustine—brain cancer	0.000551	0.00789	CcSEcCtD
Tolterodine—Abdominal pain—Procarbazine—brain cancer	0.000533	0.00763	CcSEcCtD
Tolterodine—Flushing—Temozolomide—brain cancer	0.000533	0.00763	CcSEcCtD
Tolterodine—Oedema—Hydroxyurea—brain cancer	0.000522	0.00747	CcSEcCtD
Tolterodine—Infection—Hydroxyurea—brain cancer	0.000519	0.00742	CcSEcCtD
Tolterodine—Hypersensitivity—Procarbazine—brain cancer	0.000497	0.00711	CcSEcCtD
Tolterodine—Asthenia—Procarbazine—brain cancer	0.000484	0.00693	CcSEcCtD
Tolterodine—Somnolence—Hydroxyurea—brain cancer	0.000464	0.00664	CcSEcCtD
Tolterodine—Diarrhoea—Procarbazine—brain cancer	0.000462	0.00661	CcSEcCtD
Tolterodine—Dyspepsia—Hydroxyurea—brain cancer	0.00046	0.00658	CcSEcCtD
Tolterodine—Angioedema—Temozolomide—brain cancer	0.000457	0.00654	CcSEcCtD
Tolterodine—Fatigue—Hydroxyurea—brain cancer	0.00045	0.00644	CcSEcCtD
Tolterodine—Vertigo—Temozolomide—brain cancer	0.000449	0.00643	CcSEcCtD
Tolterodine—Pain—Hydroxyurea—brain cancer	0.000446	0.00639	CcSEcCtD
Tolterodine—Constipation—Hydroxyurea—brain cancer	0.000446	0.00639	CcSEcCtD
Tolterodine—Dizziness—Procarbazine—brain cancer	0.000446	0.00639	CcSEcCtD
Tolterodine—Palpitations—Temozolomide—brain cancer	0.000442	0.00632	CcSEcCtD
Tolterodine—Chest pain—Carmustine—brain cancer	0.00044	0.0063	CcSEcCtD
Tolterodine—Anxiety—Carmustine—brain cancer	0.000439	0.00628	CcSEcCtD
Tolterodine—Feeling abnormal—Hydroxyurea—brain cancer	0.00043	0.00616	CcSEcCtD
Tolterodine—Flushing—Etoposide—brain cancer	0.000426	0.0061	CcSEcCtD
Tolterodine—Confusional state—Carmustine—brain cancer	0.000426	0.00609	CcSEcCtD
Tolterodine—Arthralgia—Temozolomide—brain cancer	0.000425	0.00609	CcSEcCtD
Tolterodine—Anxiety—Temozolomide—brain cancer	0.000424	0.00607	CcSEcCtD
Tolterodine—Headache—Procarbazine—brain cancer	0.000423	0.00605	CcSEcCtD
Tolterodine—Oedema—Carmustine—brain cancer	0.000422	0.00604	CcSEcCtD
Tolterodine—Infection—Carmustine—brain cancer	0.000419	0.006	CcSEcCtD
Tolterodine—Dry mouth—Temozolomide—brain cancer	0.000416	0.00596	CcSEcCtD
Tolterodine—Tachycardia—Carmustine—brain cancer	0.000412	0.0059	CcSEcCtD
Tolterodine—Confusional state—Temozolomide—brain cancer	0.000411	0.00589	CcSEcCtD
Tolterodine—Anaphylactic shock—Temozolomide—brain cancer	0.000408	0.00584	CcSEcCtD
Tolterodine—Oedema—Temozolomide—brain cancer	0.000408	0.00584	CcSEcCtD
Tolterodine—Infection—Temozolomide—brain cancer	0.000405	0.0058	CcSEcCtD
Tolterodine—Hypersensitivity—Hydroxyurea—brain cancer	0.000385	0.00551	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000384	0.0055	CcSEcCtD
Tolterodine—Somnolence—Carmustine—brain cancer	0.000375	0.00537	CcSEcCtD
Tolterodine—Asthenia—Hydroxyurea—brain cancer	0.000375	0.00536	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000372	0.00532	CcSEcCtD
Tolterodine—Somnolence—Temozolomide—brain cancer	0.000363	0.00519	CcSEcCtD
Tolterodine—Pain—Carmustine—brain cancer	0.000361	0.00517	CcSEcCtD
Tolterodine—Constipation—Carmustine—brain cancer	0.000361	0.00517	CcSEcCtD
Tolterodine—Vertigo—Etoposide—brain cancer	0.000359	0.00514	CcSEcCtD
Tolterodine—Dyspepsia—Temozolomide—brain cancer	0.000359	0.00514	CcSEcCtD
Tolterodine—Diarrhoea—Hydroxyurea—brain cancer	0.000357	0.00511	CcSEcCtD
Tolterodine—Fatigue—Temozolomide—brain cancer	0.000352	0.00503	CcSEcCtD
Tolterodine—Constipation—Temozolomide—brain cancer	0.000349	0.00499	CcSEcCtD
Tolterodine—Pain—Temozolomide—brain cancer	0.000349	0.00499	CcSEcCtD
Tolterodine—Feeling abnormal—Carmustine—brain cancer	0.000348	0.00498	CcSEcCtD
Tolterodine—Dizziness—Hydroxyurea—brain cancer	0.000345	0.00494	CcSEcCtD
Tolterodine—Gastrointestinal pain—Carmustine—brain cancer	0.000345	0.00494	CcSEcCtD
Tolterodine—Chest pain—Etoposide—brain cancer	0.00034	0.00487	CcSEcCtD
Tolterodine—Feeling abnormal—Temozolomide—brain cancer	0.000336	0.00481	CcSEcCtD
Tolterodine—Abdominal pain—Carmustine—brain cancer	0.000334	0.00478	CcSEcCtD
Tolterodine—Gastrointestinal pain—Temozolomide—brain cancer	0.000333	0.00477	CcSEcCtD
Tolterodine—Confusional state—Etoposide—brain cancer	0.000329	0.00471	CcSEcCtD
Tolterodine—Headache—Hydroxyurea—brain cancer	0.000327	0.00468	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—brain cancer	0.000326	0.00467	CcSEcCtD
Tolterodine—Infection—Etoposide—brain cancer	0.000324	0.00464	CcSEcCtD
Tolterodine—Abdominal pain—Temozolomide—brain cancer	0.000322	0.00462	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—brain cancer	0.000318	0.00456	CcSEcCtD
Tolterodine—Hypersensitivity—Carmustine—brain cancer	0.000311	0.00445	CcSEcCtD
Tolterodine—Asthenia—Carmustine—brain cancer	0.000303	0.00433	CcSEcCtD
Tolterodine—Hypersensitivity—Temozolomide—brain cancer	0.0003	0.0043	CcSEcCtD
Tolterodine—Asthenia—Temozolomide—brain cancer	0.000293	0.00419	CcSEcCtD
Tolterodine—Somnolence—Etoposide—brain cancer	0.00029	0.00415	CcSEcCtD
Tolterodine—Diarrhoea—Carmustine—brain cancer	0.000289	0.00413	CcSEcCtD
Tolterodine—Fatigue—Etoposide—brain cancer	0.000281	0.00403	CcSEcCtD
Tolterodine—Dizziness—Carmustine—brain cancer	0.000279	0.004	CcSEcCtD
Tolterodine—Pain—Etoposide—brain cancer	0.000279	0.004	CcSEcCtD
Tolterodine—Constipation—Etoposide—brain cancer	0.000279	0.004	CcSEcCtD
Tolterodine—Diarrhoea—Temozolomide—brain cancer	0.000279	0.00399	CcSEcCtD
Tolterodine—Dizziness—Temozolomide—brain cancer	0.00027	0.00386	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—brain cancer	0.000269	0.00385	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—brain cancer	0.000267	0.00382	CcSEcCtD
Tolterodine—Headache—Carmustine—brain cancer	0.000264	0.00378	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—brain cancer	0.000258	0.00369	CcSEcCtD
Tolterodine—Headache—Temozolomide—brain cancer	0.000255	0.00366	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—brain cancer	0.00024	0.00344	CcSEcCtD
Tolterodine—Asthenia—Etoposide—brain cancer	0.000234	0.00335	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—brain cancer	0.000223	0.0032	CcSEcCtD
Tolterodine—Dizziness—Etoposide—brain cancer	0.000216	0.00309	CcSEcCtD
Tolterodine—Headache—Etoposide—brain cancer	0.000204	0.00293	CcSEcCtD
Tolterodine—CHRM2—Signaling Pathways—DTX2—brain cancer	2.77e-05	0.00131	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—SHH—brain cancer	2.75e-05	0.0013	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TRPC6—brain cancer	2.66e-05	0.00126	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—SHH—brain cancer	2.64e-05	0.00125	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—SMO—brain cancer	2.61e-05	0.00123	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PTCH1—brain cancer	2.61e-05	0.00123	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.55e-05	0.00121	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TRPC6—brain cancer	2.54e-05	0.0012	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PTCH1—brain cancer	2.5e-05	0.00118	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—SMO—brain cancer	2.5e-05	0.00118	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ABR—brain cancer	2.48e-05	0.00117	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.41e-05	0.00114	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GLI2—brain cancer	2.39e-05	0.00113	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ABR—brain cancer	2.37e-05	0.00112	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GLI2—brain cancer	2.29e-05	0.00108	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP2C9—brain cancer	2.26e-05	0.00107	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GLI1—brain cancer	2.25e-05	0.00106	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.25e-05	0.00106	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.25e-05	0.00106	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.2e-05	0.00104	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—VAV1—brain cancer	2.19e-05	0.00104	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GLI1—brain cancer	2.15e-05	0.00102	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SUFU—brain cancer	2.13e-05	0.00101	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTCH2—brain cancer	2.13e-05	0.00101	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	2.12e-05	0.001	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTCH2—brain cancer	2.12e-05	0.001	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	2.12e-05	0.001	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTCH2—brain cancer	2.1e-05	0.000994	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—VAV1—brain cancer	2.1e-05	0.000992	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	2.1e-05	0.000992	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HES5—brain cancer	2.06e-05	0.000975	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GFAP—brain cancer	2.06e-05	0.000973	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HES5—brain cancer	2.06e-05	0.000972	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SUFU—brain cancer	2.04e-05	0.000966	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HES5—brain cancer	2.04e-05	0.000963	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STRADA—brain cancer	2e-05	0.000947	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STRADA—brain cancer	2e-05	0.000944	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—VAV1—brain cancer	1.99e-05	0.000941	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STRADA—brain cancer	1.98e-05	0.000935	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	1.97e-05	0.000933	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GFAP—brain cancer	1.97e-05	0.000932	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	1.97e-05	0.00093	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HEY1—brain cancer	1.95e-05	0.000923	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	1.95e-05	0.000921	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—BSG—brain cancer	1.92e-05	0.00091	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DLL1—brain cancer	1.91e-05	0.000905	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—VAV1—brain cancer	1.91e-05	0.000901	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HEY1—brain cancer	1.87e-05	0.000884	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—SHH—brain cancer	1.86e-05	0.000878	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—SHH—brain cancer	1.85e-05	0.000875	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—SHH—brain cancer	1.83e-05	0.000867	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DLL1—brain cancer	1.83e-05	0.000867	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	1.79e-05	0.000847	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	1.78e-05	0.000844	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	1.77e-05	0.000836	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—SMO—brain cancer	1.76e-05	0.000833	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	1.76e-05	0.000833	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—SMO—brain cancer	1.75e-05	0.00083	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	1.75e-05	0.00083	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—SMO—brain cancer	1.74e-05	0.000822	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	1.74e-05	0.000822	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ABR—brain cancer	1.67e-05	0.00079	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ABR—brain cancer	1.67e-05	0.000788	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—IDH1—brain cancer	1.65e-05	0.000782	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ABR—brain cancer	1.65e-05	0.00078	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SHH—brain cancer	1.63e-05	0.000769	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GLI2—brain cancer	1.61e-05	0.000763	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GLI2—brain cancer	1.61e-05	0.000761	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GLI2—brain cancer	1.59e-05	0.000753	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.58e-05	0.000749	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.58e-05	0.000747	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TRPC6—brain cancer	1.57e-05	0.000742	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SHH—brain cancer	1.56e-05	0.000737	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTCH1—brain cancer	1.54e-05	0.000729	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SMO—brain cancer	1.54e-05	0.000729	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GLI1—brain cancer	1.52e-05	0.000718	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GLI1—brain cancer	1.51e-05	0.000715	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TRPC6—brain cancer	1.5e-05	0.00071	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GLI1—brain cancer	1.5e-05	0.000708	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	1.48e-05	0.000699	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SMO—brain cancer	1.48e-05	0.000698	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTCH1—brain cancer	1.48e-05	0.000698	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	1.47e-05	0.000696	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000696	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	1.46e-05	0.00069	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SUFU—brain cancer	1.44e-05	0.00068	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SUFU—brain cancer	1.43e-05	0.000678	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SUFU—brain cancer	1.42e-05	0.000671	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—TP53—brain cancer	1.4e-05	0.000664	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	1.39e-05	0.000658	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GFAP—brain cancer	1.39e-05	0.000656	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GFAP—brain cancer	1.38e-05	0.000654	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GFAP—brain cancer	1.37e-05	0.000648	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.35e-05	0.00064	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—VAV1—brain cancer	1.34e-05	0.000634	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—VAV1—brain cancer	1.34e-05	0.000632	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	1.33e-05	0.00063	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—VAV1—brain cancer	1.32e-05	0.000626	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HEY1—brain cancer	1.32e-05	0.000622	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HEY1—brain cancer	1.31e-05	0.00062	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ENO2—brain cancer	1.31e-05	0.000618	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HEY1—brain cancer	1.3e-05	0.000614	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DLL1—brain cancer	1.29e-05	0.00061	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DLL1—brain cancer	1.29e-05	0.000608	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DLL1—brain cancer	1.27e-05	0.000602	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	1.26e-05	0.000597	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—BSG—brain cancer	1.25e-05	0.000591	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	1.23e-05	0.000583	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	1.21e-05	0.000572	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	1.18e-05	0.000558	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VAV1—brain cancer	1.18e-05	0.000556	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—BSG—brain cancer	1.15e-05	0.000544	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—BSG—brain cancer	1.14e-05	0.000539	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VAV1—brain cancer	1.13e-05	0.000532	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SHH—brain cancer	1.1e-05	0.000519	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SHH—brain cancer	1.09e-05	0.000517	CbGpPWpGaD
Tolterodine—CHRM4—head—brain cancer	1.08e-05	0.0488	CbGeAlD
Tolterodine—CHRM2—Signaling Pathways—SHH—brain cancer	1.08e-05	0.000512	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—IDH1—brain cancer	1.08e-05	0.000509	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TRPC6—brain cancer	1.06e-05	0.0005	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TRPC6—brain cancer	1.05e-05	0.000499	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TRPC6—brain cancer	1.04e-05	0.000494	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTCH1—brain cancer	1.04e-05	0.000492	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SMO—brain cancer	1.04e-05	0.000492	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTCH1—brain cancer	1.04e-05	0.00049	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SMO—brain cancer	1.04e-05	0.00049	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTCH1—brain cancer	1.03e-05	0.000485	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SMO—brain cancer	1.03e-05	0.000485	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HES1—brain cancer	1.01e-05	0.000478	CbGpPWpGaD
Tolterodine—CHRM4—central nervous system—brain cancer	9.89e-06	0.0446	CbGeAlD
Tolterodine—CYP2D6—Metabolism—IDH1—brain cancer	9.89e-06	0.000468	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—IDH1—brain cancer	9.8e-06	0.000464	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—IL2—brain cancer	9.79e-06	0.000463	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HES1—brain cancer	9.68e-06	0.000458	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	9.62e-06	0.000455	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	9.38e-06	0.000444	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—IL2—brain cancer	9.37e-06	0.000443	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	9.35e-06	0.000442	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SPP1—brain cancer	9.34e-06	0.000442	CbGpPWpGaD
Tolterodine—CHRM2—telencephalon—brain cancer	9.34e-06	0.0421	CbGeAlD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	9.26e-06	0.000438	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	9.22e-06	0.000436	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SPP1—brain cancer	8.95e-06	0.000423	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL2—brain cancer	8.89e-06	0.00042	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2C9—brain cancer	8.84e-06	0.000418	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.76e-06	0.000414	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	8.52e-06	0.000403	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2—brain cancer	8.51e-06	0.000403	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ENO2—brain cancer	8.5e-06	0.000402	CbGpPWpGaD
Tolterodine—CHRM1—telencephalon—brain cancer	8.5e-06	0.0383	CbGeAlD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	8.49e-06	0.000402	CbGpPWpGaD
Tolterodine—CHRM5—head—brain cancer	8.47e-06	0.0382	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—IRS2—brain cancer	8.45e-06	0.0004	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	8.41e-06	0.000398	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	8.31e-06	0.000393	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	8.29e-06	0.000392	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	8.21e-06	0.000388	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IRS2—brain cancer	8.09e-06	0.000383	CbGpPWpGaD
Tolterodine—CYP2D6—hindbrain—brain cancer	8.09e-06	0.0364	CbGeAlD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.98e-06	0.000378	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VAV1—brain cancer	7.92e-06	0.000375	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VAV1—brain cancer	7.9e-06	0.000374	CbGpPWpGaD
Tolterodine—CHRM4—brain—brain cancer	7.85e-06	0.0354	CbGeAlD
Tolterodine—CHRM2—Signaling Pathways—VAV1—brain cancer	7.82e-06	0.00037	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ENO2—brain cancer	7.82e-06	0.00037	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ENO2—brain cancer	7.75e-06	0.000367	CbGpPWpGaD
Tolterodine—CHRM5—central nervous system—brain cancer	7.73e-06	0.0349	CbGeAlD
Tolterodine—CHRM3—telencephalon—brain cancer	7.61e-06	0.0343	CbGeAlD
Tolterodine—CYP3A4—Metabolism—BSG—brain cancer	7.52e-06	0.000356	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APC—brain cancer	7.46e-06	0.000353	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	7.46e-06	0.000353	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	7.15e-06	0.000338	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APC—brain cancer	7.15e-06	0.000338	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HES1—brain cancer	6.82e-06	0.000322	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—EGFR—brain cancer	6.8e-06	0.000322	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HES1—brain cancer	6.79e-06	0.000321	CbGpPWpGaD
Tolterodine—KCNH2—telencephalon—brain cancer	6.74e-06	0.0304	CbGeAlD
Tolterodine—CHRM2—Signaling Pathways—HES1—brain cancer	6.73e-06	0.000318	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2—brain cancer	6.6e-06	0.000312	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2—brain cancer	6.58e-06	0.000311	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2—brain cancer	6.52e-06	0.000308	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—EGFR—brain cancer	6.51e-06	0.000308	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	6.49e-06	0.000307	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	6.47e-06	0.000306	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—IDH1—brain cancer	6.47e-06	0.000306	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	6.41e-06	0.000303	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SPP1—brain cancer	6.3e-06	0.000298	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SPP1—brain cancer	6.28e-06	0.000297	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SPP1—brain cancer	6.22e-06	0.000294	CbGpPWpGaD
Tolterodine—CHRM5—brain—brain cancer	6.14e-06	0.0277	CbGeAlD
Tolterodine—CHRM3—Metabolism—PIK3CG—brain cancer	6e-06	0.000284	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—brain cancer	5.99e-06	0.000283	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—brain cancer	5.97e-06	0.000283	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—brain cancer	5.92e-06	0.00028	CbGpPWpGaD
Tolterodine—CHRM2—endocrine gland—brain cancer	5.89e-06	0.0265	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—RELA—brain cancer	5.83e-06	0.000276	CbGpPWpGaD
Tolterodine—CHRM2—head—brain cancer	5.81e-06	0.0262	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—ERBB2—brain cancer	5.79e-06	0.000274	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS2—brain cancer	5.7e-06	0.000269	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS2—brain cancer	5.68e-06	0.000269	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS2—brain cancer	5.62e-06	0.000266	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RELA—brain cancer	5.58e-06	0.000264	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ERBB2—brain cancer	5.55e-06	0.000262	CbGpPWpGaD
Tolterodine—KCNH2—pituitary gland—brain cancer	5.49e-06	0.0248	CbGeAlD
Tolterodine—CHRM1—endocrine gland—brain cancer	5.36e-06	0.0242	CbGeAlD
Tolterodine—CHRM2—central nervous system—brain cancer	5.31e-06	0.0239	CbGeAlD
Tolterodine—KCNH2—medulla oblongata—brain cancer	5.3e-06	0.0239	CbGeAlD
Tolterodine—CHRM1—head—brain cancer	5.29e-06	0.0239	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—IL2—brain cancer	5.25e-06	0.000248	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCND1—brain cancer	5.12e-06	0.000242	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ENO2—brain cancer	5.11e-06	0.000242	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	5.07e-06	0.00024	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	5.03e-06	0.000238	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APC—brain cancer	5.03e-06	0.000238	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—brain cancer	5.03e-06	0.000238	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APC—brain cancer	5.02e-06	0.000237	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	5.02e-06	0.000237	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APC—brain cancer	4.97e-06	0.000235	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	4.97e-06	0.000235	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCND1—brain cancer	4.9e-06	0.000232	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	4.85e-06	0.00023	CbGpPWpGaD
Tolterodine—KCNH2—midbrain—brain cancer	4.84e-06	0.0218	CbGeAlD
Tolterodine—CHRM1—central nervous system—brain cancer	4.83e-06	0.0218	CbGeAlD
Tolterodine—CHRM3—endocrine gland—brain cancer	4.8e-06	0.0216	CbGeAlD
Tolterodine—CHRM3—head—brain cancer	4.74e-06	0.0213	CbGeAlD
Tolterodine—KCNH2—spinal cord—brain cancer	4.73e-06	0.0213	CbGeAlD
Tolterodine—CYP2D6—brainstem—brain cancer	4.63e-06	0.0209	CbGeAlD
Tolterodine—CHRM1—Signaling by GPCR—EGFR—brain cancer	4.58e-06	0.000217	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EGFR—brain cancer	4.57e-06	0.000216	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EGFR—brain cancer	4.53e-06	0.000214	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—brain cancer	4.46e-06	0.000211	CbGpPWpGaD
Tolterodine—CYP2C19—endocrine gland—brain cancer	4.46e-06	0.0201	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—STAT3—brain cancer	4.42e-06	0.000209	CbGpPWpGaD
Tolterodine—CHRM3—central nervous system—brain cancer	4.32e-06	0.0195	CbGeAlD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—brain cancer	4.27e-06	0.000202	CbGpPWpGaD
Tolterodine—KCNH2—endocrine gland—brain cancer	4.25e-06	0.0192	CbGeAlD
Tolterodine—CHRM5—Signaling Pathways—STAT3—brain cancer	4.23e-06	0.0002	CbGpPWpGaD
Tolterodine—CHRM2—brain—brain cancer	4.21e-06	0.019	CbGeAlD
Tolterodine—KCNH2—head—brain cancer	4.2e-06	0.0189	CbGeAlD
Tolterodine—CYP2D6—telencephalon—brain cancer	4.11e-06	0.0185	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—MYC—brain cancer	4.11e-06	0.000194	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGFR—brain cancer	4.02e-06	0.00019	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—brain cancer	3.93e-06	0.000186	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RELA—brain cancer	3.93e-06	0.000186	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RELA—brain cancer	3.92e-06	0.000185	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ERBB2—brain cancer	3.91e-06	0.000185	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CG—brain cancer	3.9e-06	0.000184	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ERBB2—brain cancer	3.89e-06	0.000184	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RELA—brain cancer	3.88e-06	0.000184	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ERBB2—brain cancer	3.86e-06	0.000182	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGFR—brain cancer	3.85e-06	0.000182	CbGpPWpGaD
Tolterodine—CHRM1—brain—brain cancer	3.84e-06	0.0173	CbGeAlD
Tolterodine—KCNH2—central nervous system—brain cancer	3.83e-06	0.0173	CbGeAlD
Tolterodine—KCNH2—cerebellum—brain cancer	3.75e-06	0.0169	CbGeAlD
Tolterodine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.59e-06	0.00017	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.56e-06	0.000168	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—brain cancer	3.54e-06	0.000167	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—brain cancer	3.53e-06	0.000167	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—brain cancer	3.5e-06	0.000165	CbGpPWpGaD
Tolterodine—CYP2C9—endocrine gland—brain cancer	3.46e-06	0.0156	CbGeAlD
Tolterodine—CHRM1—Signaling Pathways—CCND1—brain cancer	3.45e-06	0.000163	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCND1—brain cancer	3.44e-06	0.000163	CbGpPWpGaD
Tolterodine—CHRM3—brain—brain cancer	3.43e-06	0.0155	CbGeAlD
Tolterodine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	3.42e-06	0.000162	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCND1—brain cancer	3.41e-06	0.000161	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	3.41e-06	0.000161	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.37e-06	0.00016	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—brain cancer	3.37e-06	0.000159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—brain cancer	3.23e-06	0.000153	CbGpPWpGaD
Tolterodine—KCNH2—brain—brain cancer	3.04e-06	0.0137	CbGeAlD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.01e-06	0.000142	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—brain cancer	3e-06	0.000142	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—brain cancer	2.98e-06	0.000141	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—brain cancer	2.97e-06	0.00014	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—brain cancer	2.97e-06	0.00014	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—brain cancer	2.94e-06	0.000139	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—brain cancer	2.77e-06	0.000131	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—brain cancer	2.76e-06	0.000131	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—brain cancer	2.73e-06	0.000129	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGFR—brain cancer	2.71e-06	0.000128	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGFR—brain cancer	2.7e-06	0.000128	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGFR—brain cancer	2.67e-06	0.000126	CbGpPWpGaD
Tolterodine—CYP3A4—endocrine gland—brain cancer	2.64e-06	0.0119	CbGeAlD
Tolterodine—CYP2D6—endocrine gland—brain cancer	2.59e-06	0.0117	CbGeAlD
Tolterodine—CYP2D6—head—brain cancer	2.56e-06	0.0115	CbGeAlD
Tolterodine—CYP3A4—central nervous system—brain cancer	2.38e-06	0.0107	CbGeAlD
Tolterodine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.34e-06	0.000111	CbGpPWpGaD
Tolterodine—CYP2D6—central nervous system—brain cancer	2.34e-06	0.0105	CbGeAlD
Tolterodine—CYP2D6—cerebellum—brain cancer	2.29e-06	0.0103	CbGeAlD
Tolterodine—CHRM1—Signaling Pathways—TP53—brain cancer	2.27e-06	0.000108	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—brain cancer	2.27e-06	0.000107	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—brain cancer	2.24e-06	0.000106	CbGpPWpGaD
Tolterodine—CYP2D6—brain—brain cancer	1.86e-06	0.00837	CbGeAlD
